ArticleFrontiers in neurology2025
Rising global burden of migraine among adolescents and young adults: a 30-year analysis (1990-2021).
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Magnesium supplementation for migraine prophylaxis.The Cochrane database of systematic reviews · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migraine significantly impacts the physical and mental health of adolescents and young adults (AYA, aged 10-24 years). This study aims to assess global trends in migraine incidence, prevalence, and DALYs in this age group from 1990 to 2021, providing evidence to guide prevention and policy efforts. Materials and methods: Data were obtained from the Global Burden of Disease (GBD) 2021 study, encompassing AYA's migraine burden across 204 countries and territories over the past 30 years, stratified by sex, age, socio-demographic index (SDI), location and year. The assessment analyzed incidence, prevalence, and disability-adjusted life years (DALYs). Results: Between 1990 and 2021, the global burden of migraine among AYA increased markedly in terms of absolute case numbers. Incident cases rose by 23.50%, prevalent cases by 24.82%, and DALYs by 24.94%. Despite these increases, the overall rates and age-standardized rates (ASRs) remained relatively stable, suggesting that population growth and aging are key drivers. The burden was consistently higher in females and in high-SDI regions; however, the rate of increase was greater in males, gradually narrowing the sex gap. Age-wise, those aged 10-14 had the highest incidence rate (45.9%), while the 20-24 group bore the greatest prevalence (39.8%) and DALY burden (39.9%). Among 21 regions, Western Europe recorded the highest ASIR (2272.50 per 100,000), while Tropical Latin America had the highest ASPR (27542.29 per 100,000) and ASDR (1011.78 per 100,000). Nationally, Belgium had the highest ASIR (2758.02 per 100,000), and Brazil had the highest ASPR (27592.69 per 100,000) and ASDR (1013.43 per 100,000). However, projections indicated that ASIR, ASPR, and ASDR will continue to rise by 2035. Conclusion: Global migraine burden surged (1990-2021), with high-SDI regions facing highest DALYs and low-SDI areas underdiagnosed. AYA (10-14, especially females) show peak incidence due to hormonal/social factors. Despite projected ASR decline, cases will rise, demanding precision interventions: healthcare access, sex-specific strategies, and school-based programs. Urgent global efforts are required to promote equitable access to migraine care and prevention, as well as to advance research on emerging risk factors, such as air pollution, prolonged screen exposure, chronic stress, academic pressure, and others.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.